Predicting molecular phenotypes from histopathology images: a transcriptome-wide expression-morphology analysis in breast cancer

• URL: http://arxiv.org/abs/2009.08917v1
• Date: Fri, 18 Sep 2020 16:27:53 GMT
• Title: Predicting molecular phenotypes from histopathology images: a transcriptome-wide expression-morphology analysis in breast cancer
• Authors: Yinxi Wang, Kimmo Kartasalo, Masi Valkonen, Christer Larsson, Pekka Ruusuvuori, Johan Hartman, Mattias Rantalainen
• Abstract summary: We report the first transcriptome-wide Expression-MOrphology (EMO) analysis in breast cancer. Gene-specific models were optimised and validated for prediction of mRNA expression. Predictions for 9,334 genes were significantly associated with RNA-sequencing estimates.
• Score: 1.3758771225117674
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Molecular phenotyping is central in cancer precision medicine, but remains costly and standard methods only provide a tumour average profile. Microscopic morphological patterns observable in histopathology sections from tumours are determined by the underlying molecular phenotype and associated with clinical factors. The relationship between morphology and molecular phenotype has a potential to be exploited for prediction of the molecular phenotype from the morphology visible in histopathology images. We report the first transcriptome-wide Expression-MOrphology (EMO) analysis in breast cancer, where gene-specific models were optimised and validated for prediction of mRNA expression both as a tumour average and in spatially resolved manner. Individual deep convolutional neural networks (CNNs) were optimised to predict the expression of 17,695 genes from hematoxylin and eosin (HE) stained whole slide images (WSIs). Predictions for 9,334 (52.75%) genes were significantly associated with RNA-sequencing estimates (FDR adjusted p-value < 0.05). 1,011 of the genes were brought forward for validation, with 876 (87%) and 908 (90%) successfully replicated in internal and external test data, respectively. Predicted spatial intra-tumour variabilities in expression were validated in 76 genes, out of which 59 (77.6%) had a significant association (FDR adjusted p-value < 0.05) with spatial transcriptomics estimates. These results suggest that the proposed methodology can be applied to predict both tumour average gene expression and intra-tumour spatial expression directly from morphology, thus providing a scalable approach to characterise intra-tumour heterogeneity.

Related papers

• TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs [49.69047720285225]
  We propose a novel topological approach that explicitly extracts multi-scale topological structures to better approximate breast parenchymal structures. We empirically validate emphTopoTxR using the VICTRE phantom breast dataset. Our qualitative and quantitative analyses suggest differential topological behavior of breast tissue in treatment-na"ive imaging.
  arXiv  Detail & Related papers  (2024-11-05T19:35:10Z)
• hist2RNA: An efficient deep learning architecture to predict gene expression from breast cancer histopathology images [11.822321981275232]
  Deep learning algorithms can effectively extract morphological patterns in digital histopathology images to predict molecular phenotypes quickly and cost-effectively. We propose a new, computationally efficient approach called hist2RNA inspired by bulk RNA-sequencing techniques to predict the expression of 138 genes.
  arXiv  Detail & Related papers  (2023-04-10T10:54:32Z)
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging [59.79875531898648]
  DeepGlioma is an artificial-intelligence-based diagnostic screening system. DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy.
  arXiv  Detail & Related papers  (2023-03-23T18:50:18Z)
• Breast Cancer Histopathology Image based Gene Expression Prediction using Spatial Transcriptomics data and Deep Learning [3.583756449759971]
  We present BrST-Net, a deep learning framework for predicting gene expression from histopathology images. We trained and evaluated 10 state-of-the-art deep learning models without utilizing pretrained weights for the prediction of 250 genes. Our methodology outperforms previous studies, with 237 genes identified with positive correlation, including 24 genes with a median correlation coefficient greater than 0.50.
  arXiv  Detail & Related papers  (2023-03-17T14:03:40Z)
• Machine Learning Methods for Cancer Classification Using Gene Expression Data: A Review [77.34726150561087]
  Cancer is the second major cause of death after cardiovascular diseases. Gene expression can play a fundamental role in the early detection of cancer. This study reviews recent progress in gene expression analysis for cancer classification using machine learning methods.
  arXiv  Detail & Related papers  (2023-01-28T15:03:03Z)
• rfPhen2Gen: A machine learning based association study of brain imaging phenotypes to genotypes [71.1144397510333]
  We learned machine learning models to predict SNPs using 56 brain imaging QTs. SNPs within the known Alzheimer disease (AD) risk gene APOE had lowest RMSE for lasso and random forest. Random forests identified additional SNPs that were not prioritized by the linear models but are known to be associated with brain-related disorders.
  arXiv  Detail & Related papers  (2022-03-31T20:15:22Z)
• All You Need is Color: Image based Spatial Gene Expression Prediction using Neural Stain Learning [11.9045433112067]
  We propose a "stain-aware" machine learning approach for prediction of spatial transcriptomic gene expression profiles. We have found that the gene expression predictions from the proposed approach show higher correlations with true expression values obtained through sequencing.
  arXiv  Detail & Related papers  (2021-08-23T23:43:38Z)
• Pan-Cancer Integrative Histology-Genomic Analysis via Interpretable Multimodal Deep Learning [4.764927152701701]
  We integrate whole slide pathology images, RNA-seq abundance, copy number variation, and mutation data from 5,720 patients across 14 major cancer types. Our interpretable, weakly-supervised, multimodal deep learning algorithm is able to fuse these heterogeneous modalities for predicting outcomes. We analyze morphologic and molecular markers responsible for prognostic predictions across all cancer types.
  arXiv  Detail & Related papers  (2021-08-04T20:40:05Z)
• Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression based convolutional neural networks [0.8874479658912061]
  We propose a new, computationally efficient approach for disease specific modelling of relationships between morphology and gene expression. We conducted the first transcriptome-wide analysis in prostate cancer, using CNNs to predict bulk RNA-sequencing estimates.
  arXiv  Detail & Related papers  (2021-04-19T13:50:25Z)
• Cancer Gene Profiling through Unsupervised Discovery [49.28556294619424]
  We introduce a novel, automatic and unsupervised framework to discover low-dimensional gene biomarkers. Our method is based on the LP-Stability algorithm, a high dimensional center-based unsupervised clustering algorithm. Our signature reports promising results on distinguishing immune inflammatory and immune desert tumors.
  arXiv  Detail & Related papers  (2021-02-11T09:04:45Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.